DjordjeAtanackovicMD

PubMed

• Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising vir...
  Kocoglu, M., Richardson, P., Mo, C., Rapoport, A., Atanackovic, D.> ;Haematologica. 2024 Feb 22
• Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
  Kline, K., Luetkens, T., Koka, R., Kallen, M., Chen, W., Ahmad, H., Omili, D., Iraguha, T., Gebru, E., Fan, X., Miller, A., Dishanthan, N., Baker, J., Dietze, K., Hank...> ;Cancer Immunology, Immunotherapy. 2024 Feb 13
• Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
  Morales, E., Dietze, K., Baker, J., Wang, A., Avila, S., Iglesias, F., Mause, E., Olson, M., Sun, W., Rosati, E., Chidester, S., Iraguha, T., Fan, X., Luetkens, T., Ra...> ;Biorxiv. 2024 Feb 11
• A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
  Djordje Atanackovic, Thierry Iraguha, Destiny Omili, Stephanie V Avila, Xiaoxuan Fan, Mehmet Kocoglu, Etse Gebru, Jillian M Baker, Nishanthini Dishanthan, Kenneth A Di...> ;Cytotherapy. 2024 Apr 1
• 1 citations
  Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma.
  Kamlesh Bisht, Taro Fukao, Marielle Chiron, Paul Richardson, Djordje Atanackovic, Eduardo Chini, Wee Joo Chng, Helgi Van De Velde, Fabio Malavasi> ;Cancer Medicine. 2023 Oct 1
• 3 citations
  Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response byF-FDG PET/CT Imaging Following CAR-T Therapy.
  Lutfi, F., Goloubeva, O., Kowatli, A., Gryaznov, A., Kim, D., Dureja, R., Margiotta, P., Matsumoto, L., Bukhari, A., Ahmed, N., Mushtaq, M., Law, J., Lee, S., Kocoglu,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Oct 1
• Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
  Yamini K Kathari, Haroon Ahmad, Michael E Kallen, Rima Koka, Destiny Omili, Thierry Iraguha, Jean Clement, Lily Pham, Mazhar Khalid, Xiaoxuan Fan, Etse Gebru, Patricia...> ;Haematologica. 2024 Feb 1
• 2 citations
  Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
  Erica R Vander Mause, Jillian M Baker, Kenneth A Dietze, Sabarinath V Radhakrishnan, Thierry Iraguha, Destiny Omili, Patricia Davis, Sadie L Chidester, Katarzyna Modze...> ;Science Translational Medicine. 2023 Jul 19
• 2 citations
  Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
  Kathryn Kline, Wengen Chen, Michael E Kallen, Rima Koka, Destiny Omili, Xiaoxuan Fan, Thierry Iraguha, Etse Gebru, Nishanthini Dishanthan, Jillian M Baker, Kenneth A D...> ;Human Vaccines & Immunotherapeutics. 2023 Aug 1
• 1 citations
  Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Ste...
  Hanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Yifan Pang, Moaath Mustafa Ali, Nancy M Hardy, Pranshu Mohindra, Ali Bukhari, Forat Lutfi, Gabriela S...> ;Transplantation Proceedings. 2023 Jan 11
• 16 citations
  Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
  Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M Hardy, Xiaoxuan Fan, Stephanie V Avila, Kapil K Saharia, Jennifer S Husson, Sil...> ;Blood. 2022 Jul 14
• 14 citations
  Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.
  Erica R Vander Mause, Djordje Atanackovic, Carol S Lim, Tim Luetkens> ;Trends in Biotechnology. 2022 Jul 1
• 6 citations
  T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
  Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, Nancy M Hardy, Destiny Omili, Thierry Iraguha, Peter D Burbelo, Etse Gebru, Xiaoxuan Fan, Tim Luetkens, Saurabh ...> ;Journal for Immunotherapy of Cancer. 2022 Jul 1
• 38 citations
  Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion.
  Michael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, Joshua D Brody, Aaron P Rapoport, Alana L Welm, Djordje Atanackovic, Tim Luetkens> ;Leukemia. 2022 Jul 1
• 4 citations
  Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
  Aisha A Mumtaz, Andrew Fischer, Forat Lutfi, Lisa R Matsumoto, Djordje Atanackovic, Elif T Kolanci, Kim G Hankey, Nancy M Hardy, Jean A Yared, Mehmet H Kocoglu, Aaron ...> ;The British Journal of Ophthalmology. 2023 Jul 1
• 17 citations
  Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy.
  Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie Avila, Thierry Iraguha, Philip Margiotta, Kim G Hankey, Patricia Lesho, Jennie Y Law, Seung T Lee, John Baddley, M...> ;Blood Advances. 2022 Jan 25
• 21 citations
  Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
  Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Youngchae J Yoo, Nancy M Hardy, Xiaoxuan Fan, Destiny Omili, Alice Crane, A...> ;Clinical & Translational Immunology. 2022 Jan 1
• 8 citations
  Deep dissection of the antiviral immune profile of patients with COVID-19.
  Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, Diego de Miguel-Perez, Xiaoxuan Fan, Gabriela Sanchez-Petitto, Erica Vander Mause, Jonathan Siglin, John Baddley, ...> ;Communications Biology. 2021 Dec 16
• 6 citations
  Targeting the tumor microenvironment of Ewing sarcoma.
  Erin Morales, Michael L. Olson, Fiorella Iglesias, Tim Luetkens, Djordje Atanackovic> ;Immunotherapy. 2021 Oct 21
• 9 citations
  The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
  Forat Lutfi, Noa G. Holtzman, Ankit Kansagra, Moaath K. Mustafa Ali, Ali Bukhari, Jingsheng Yan, Santanu Samanta, David Gottlieb, Dong Won Kim, Lisa R. Matsumoto, Nata...> ;British Journal of Haematology. 2021 Sep 9
• 5 citations
  Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant.
  Djordje Atanackovic, Tim Luetkens, Stephanie Avila, Nancy M. Hardy, Forat Lutfi, Gabriela Sanchez-Petitto, Erica Vander Mause, Nicole M. Glynn, Heather D. Mannuel, Han...> ;Vaccines. 2021 Jul 3
• 47 citations
  A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
  Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, Laure Vincent, Philippe Moreau, Cristina Gasparetto, Ludek Pour, Ivan Spicka, Ravi Vij, Jeffrey A. Zonder, Djordj...> ;Blood Cancer Journal. 2021 May 12
• 36 citations
  Role of immunotherapy in Ewing sarcoma.
  Erin Morales, Michael Olson, Fiorella Iglesias, Saurabh Dahiya, Tim Luetkens, Djordje Atanackovic> ;Journal for Immunotherapy of Cancer. 2020 Dec 1
• 14 citations
  Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
  Tim Luetkens, Ryan A. Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S Spivak, Adam M. Spivak, Mary Steinbach, Robert C. Blaylock, Stephanie V. Avila...> ;Blood Advances. 2020 Oct 13
• 11 citations
  A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer
  Benjamin Dizier, Andrea Callegaro, Muriel Debois, Brigitte Dréno, Peter Hersey, Helen Gogas, John M. Kirkwood, Johan Vansteenkiste, Lecia V. Sequist, Djordje Atanackov...> ;Clinical Cancer Research. 2020 Apr 1
• Join now to see all

Abstracts/Posters

• B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
  Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
  Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019